Healthcare


 Market Impact: New U.S. Tariffs to Affect Pharmaceutical Sector

Market Impact: New U.S. Tariffs to Affect Pharmaceutical Sector

April 09, 2025 12:56 PM AEST| By Team Kalkine Media

Highlights,President Trump announces new tariffs on pharmaceuticals.,(CSL) shares fall following tariff news.,U.S. trade policies could reshape global pharmaceutical trade dynamics.,In a recent development that could significantly impact the pharmace...

 Orthocell Gains Ground: Brazilian Market Entry to Boost Global Presence

Orthocell Gains Ground: Brazilian Market Entry to Boost Global Presence

April 09, 2025 12:55 PM AEST| By Team Kalkine Media

Highlights,Orthocell,(OCC) approved for Striate+ in Brazil.,Strategic entry into a $65 million market.,Planned expansion across Latin America.,Orthocell (ASX:OCC), an innovator in regenerative medicine, has successfully obtained regulatory approval f...

 Transurban Group's (ASX:TCL) Steady Climb: A Look at Its Current Position and Future Prospects

Transurban Group's (ASX:TCL) Steady Climb: A Look at Its Current Position and Future Prospects

April 09, 2025 12:48 PM AEST| By Team Kalkine Media

Highlights,(TCL) has,witnessed,a 1.0% rise since the beginning of 2025.,Offers a compelling dividend yield of 4.57%, higher than its 5-year average.,Positioned to,benefit,from consistent government infrastructure spending and population growth.,Trans...

 Insider Confidence in Amplia Therapeutics Despite Market Fluctuations

Insider Confidence in Amplia Therapeutics Despite Market Fluctuations

April 09, 2025 11:47 AM AEST| By Team Kalkine Media

Highlights,Significant insider purchases reflect confidence in (ATX).,Recent,market value decline challenges,initial,optimism.,Insider ownership suggests long-term commitment to company growth.,Over the past year, insiders of Amplia Therapeutics Limi...

 Pro Medicus (ASX:PME) Gains Momentum Amid Market Volatility: Analyst Upgrade Highlights

Pro Medicus (ASX:PME) Gains Momentum Amid Market Volatility: Analyst Upgrade Highlights

April 08, 2025 03:16 PM AEST| By Team Kalkine Media

Highlights,Pro Medicus receives upgrade to overweight status.,Shares bounce back with a 6% increase.,Unchanged price target reflects ongoing confidence.,In a recent market update, Pro Medicus (ASX:PME), a leading health imaging software provider, has...

 Impressive Growth in Occupancy Sales Drives Summerset Group's Q1 Momentum

Impressive Growth in Occupancy Sales Drives Summerset Group's Q1 Momentum

April 08, 2025 02:28 PM AEST| By Team Kalkine Media

Highlights,Robust Sales Growth,: Summerset achieves a 14% year-over-year increase in Q1 2025.,Geographic Expansion,: Sales flourish across diverse New Zealand regions.,Future Developments,: Expansion plans include new homes and a village center in Au...

 Cochlear poised to avoid tariffs as countries begin negotiations with Trump

Cochlear poised to avoid tariffs as countries begin negotiations with Trump

April 08, 2025 11:30 AM AEST| By Team Kalkine Media

Highlights:,Cochlear Limited aligns with international trade classifications to maintain duty-free access for hearing implants.,Recent tariff developments underscore the importance of regulatory frameworks in the global medical device landscape.,Key...

 Why the Drop in Aroa Biosurgery Limited's (ASX:ARX) Share Price Shouldn't Surprise Investors

Why the Drop in Aroa Biosurgery Limited's (ASX:ARX) Share Price Shouldn't Surprise Investors

April 08, 2025 10:31 AM AEST| By Team Kalkine Media

Highlights,Aroa Biosurgery (ARX) shares drop 26% in 30 days.,P/S ratio stands at 1.8x, under industry average.,Future growth projections fall below industry trends.,Aroa Biosurgery Limited, trading under the ticker,(,ASX:ARX),, has witnessed a signif...

 ASX Healthcare Stock Trading Well Below Pandemic Highs with Consistent Dividends

ASX Healthcare Stock Trading Well Below Pandemic Highs with Consistent Dividends

April 07, 2025 04:35 PM AEST| By Team Kalkine Media

Highlights,Healthcare group Sonic Healthcare has seen a significant decline from its peak during the pandemic,The company operates internationally, offering pathology and diagnostic services,It has delivered consistent dividend growth across many yea...

 Mach7 Technologies Faces Market Pressure Amid Sluggish Growth Outlook

Mach7 Technologies Faces Market Pressure Amid Sluggish Growth Outlook

April 07, 2025 04:33 PM AEST| By Team Kalkine Media

Highlights,Mach7 Technologies has experienced a notable share price drop in recent weeks,The company’s price-to-sales ratio trails the broader healthcare services sector,Revenue growth expectations remain below industry projections,Mach7 Technologies...

 Atomo Diagnostics (ASX:AT1) Broadens Reach with Major Initiatives in Australia and New Zealand

Atomo Diagnostics (ASX:AT1) Broadens Reach with Major Initiatives in Australia and New Zealand

April 07, 2025 01:31 PM AEST| By Team Kalkine Media

Highlights,Expansion in Australia,:,Atomo,Diagnostics rolls out free HIV self-tests across Australia.,Launch in New Zealand,: Introduction of HIV self-test kits through Chemist Warehouse.,Executive Insight,: CEO emphasizes the importance of accessibi...

 Exploring Regis Healthcare's (ASX:REG) Revenue Growth and Market Position

Exploring Regis Healthcare's (ASX:REG) Revenue Growth and Market Position

April 07, 2025 01:29 PM AEST| By Team Kalkine Media

Highlights,Exceptional Revenue Growth,: Regis Healthcare (REG) has shown impressive revenue growth trends over recent years.,Comparative P/S Ratio,: Its price-to-sales ratio aligns closely with the industry average, despite higher growth forecasts.,h...

 Exploring Alcidion Group's Path to Profitability: A Closer Look at Its Strategic Progress

Exploring Alcidion Group's Path to Profitability: A Closer Look at Its Strategic Progress

April 07, 2025 11:20 AM AEST| By Team Kalkine Media

Highlights,Alcidion,Group (ALC) nears its breakeven point.,Projected to turn a profit by 2026 based on current growth forecasts.,Unique,position with no debt enhances financial stability.,Alcidion Group (ASX:ALC), a key player in healthcare technolog...

 Research reveals that Nyrada's leading medication can avert secondary brain injury.

Research reveals that Nyrada's leading medication can avert secondary brain injury.

April 07, 2025 10:30 AM AEST| By Team Kalkine Media

Highlights:,Nyrada Inc has released new findings from a study showing its drug candidate NYR-BI03 demonstrates neuroprotective effects following traumatic brain injury.,The research, conducted with the University of Sydney, Walter Reed Army Institute...

 Cochlear Limited's (ASX:COH) Shares May Face Unwelcome Surprises

Cochlear Limited's (ASX:COH) Shares May Face Unwelcome Surprises

April 06, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,Cochlear Limited (ASX:COH) holds a P/E ratio significantly higher than the Australian market average.,The company has demonstrated robust historical earnings growth.,Investors appear optimistic about Cochlear's future, potentially pricing...

 Oneview Healthcare (ASX:ONE) Insider Activity Overview

Oneview Healthcare (ASX:ONE) Insider Activity Overview

April 06, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,Insiders purchased more shares than they divested over the past year.,Insider ownership stands at a significant 42% of the company.,Recent insider transaction trends show confidence in future prospects.,Despite the recent 16% dip in share...

 Tryptamine Therapeutics: Insider Transactions and Ownership Insights

Tryptamine Therapeutics: Insider Transactions and Ownership Insights

April 05, 2025 05:31 PM AEDT| By Team Kalkine Media

Highlights,Founder William Garner makes significant stock purchase.,Insider ownership stands at 35% of the company.,Recent purchases suggest perceived long-term value.,In recent developments, William Garner, the Founder and Managing Director of Trypt...

 ImExHS Shows Upward Trend in Financial Performance

ImExHS Shows Upward Trend in Financial Performance

April 05, 2025 05:30 PM AEDT| By Team Kalkine Media

Highlights,ImExHS (IME) sees revenue growth by 33% in FY 2024.,Net loss narrows by 41% from the previous year.,Radiology segment leads with 68% of total revenue.,ImExHS (ASX:IME) has reported its Full Year 2024 financial results, showcasing a signifi...

 Orthocell Limited (ASX:OCC): A Study in Growth and Stability Amid Market Challenges

Orthocell Limited (ASX:OCC): A Study in Growth and Stability Amid Market Challenges

April 05, 2025 11:32 AM AEDT| By Team Kalkine Media

Highlights,Orthocell Limited (OCC) enjoys a substantial increase in share price.,The company boasts a healthy financial runway of nearly four years.,Revenue growth outstrips the rising costs associated with cash burn.,Over the past year, Orthocell Li...

 Doctor Care Anywhere Group Full Year 2024 Earnings Fall Short of Expectations

Doctor Care Anywhere Group Full Year 2024 Earnings Fall Short of Expectations

April 05, 2025 11:31 AM AEDT| By Team Kalkine Media

Highlights,Revenue rises slightly from previous fiscal year.,Net loss narrows significantly.,Forecast shows future revenue growth.,Doctor Care Anywhere Group (ASX:DOC) recently released its full-year financial results for 2024. The company reported a...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.